Similar Search Results

Pharmacy benefit management : are reporting requirements pro- or anticompetitive?

Danzon, Patricia Munch - In: International journal of the economics of business 22 (2015) 2, pp. 245-261

Persistent link: https://www.econbiz.de/10011405951

Economics of the pharmaceutical industry

Danzon, Patricia Munch - In: NBER reporter online (2006/2007) 3, pp. 14-17

Persistent link: https://www.econbiz.de/10011366977

Regulation of Price and Reimbursement For Pharmaceuticals

Danzon, Patricia M. - In: The Oxford handbook of the economics of the …. 2012

Persistent link: https://www.econbiz.de/10012881711

Pharmaceutical price regulation : national policies versus global interests

Danzon, Patricia Munch - 1997

Persistent link: https://www.econbiz.de/10013538533

Cross-national evidence on generic pharmaceuticals : pharmacy vs. physician-driven markets

Danzon, Patricia Munch; Furukawa, Michael F. - 2011

Persistent link: https://www.econbiz.de/10009240051

Regulation of the pharmaceutical-biotechnology industry

Danzon, Patricia Munch; Keuffel, Eric L. - In: Economic regulation and its reform : what have we learned?, (pp. 407-484). 2014

Persistent link: https://www.econbiz.de/10010373334

Vaccine supply : effects of regulation and competition

Danzon, Patricia Munch; Pereira, Nuno Sousa - 2011

Persistent link: https://www.econbiz.de/10009234557

Rate regulation, safety incentives, and loss growth in workers' compensation insurance

Harrington, Scott E.; Danzon, Patricia Munch - In: The journal of business : B 73 (2000) 4, pp. 569-595

Persistent link: https://www.econbiz.de/10001520114

Workers' compensation rate regulation : how price controls increase costs

Danzon, Patricia Munch; Harrington, Scott E. - In: The journal of law & economics 44 (2001) 1, pp. 1-36

Persistent link: https://www.econbiz.de/10001582710

Cross-National Evidence on Generic Pharmaceuticals : Pharmacy vs. Physician-Driven Markets

Danzon, Patricia M. - 2011

This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the...

Persistent link: https://www.econbiz.de/10013122264